Related Experiment Video
Updated: Sep 12, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.5K
Identifying dementia neuropathology using low-burden clinical data
Yueqi Ren1, Babak Shahbaba2, Craig E L Stark3
1Medical Scientist Training Program, School of Medicine, University of California Irvine, Irvine, California, USA.
Summary
Identifying dementia neuropathology is now possible using low-burden clinical data. Semi-supervised models accurately predict disease burden, improving dementia screening and clinical trials.
Area of Science:
- Neurology
- Artificial Intelligence
- Medical Informatics
Background:
- Accurate identification of dementia neuropathology is crucial for developing effective treatments and conducting clinical trials.
- Current methods often require high-burden data, limiting their applicability in primary care settings.
- Semi-supervised learning models offer a promising approach to leverage low-burden data for improved generalizability.
Purpose of the Study:
- To develop and validate semi-supervised models for identifying dementia neuropathology using low-burden clinical data.
- To enhance the utility of data obtainable in primary care settings for dementia diagnosis.
- To improve the accuracy and generalizability of neuropathology prediction models.
Main Methods:
- Defined low-burden data as data reasonably obtainable in a primary care setting.
- Employed a semi-supervised learning paradigm, including clustering and prediction models.
- Trained models to identify and predict different neuropathology lesion types.
Main Results:
- A clustering model successfully identified two distinct patient groups: those enriched and those scarce in neuropathology.
- Semi-supervised prediction models demonstrated that low-burden data from multiple visits can predict neuropathology burden comparably to higher-burden data.
- The models achieved accurate predictions across various pathology types.
Conclusions:
- This research addresses a critical need by utilizing low-burden clinical data for neuropathology prediction, enhancing dementia screening.
- The findings support the use of semi-supervised learning for dementia neuropathology identification, aiding targeted therapies and clinical trials.
- Low-burden data, particularly longitudinal data, can provide accurate predictions of pathology load, with higher-burden data being most effective for vascular lesions.
Related Concept Videos
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669

